NASDAQ: EYENEyenovia Inc Stock Ownership - Who owns Eyenovia?
Insider buying vs selling
Have Eyenovia Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael M. Rowe | Chief Executive Officer | 2024-08-28 | 27,071 | $0.52 | $14.08kBuy |
| Michael M. Rowe | Chief Executive Officer | 2024-08-26 | 50,000 | $0.57 | $28.50kBuy |
| Stuart M. Grant | 10% Owner | 2024-07-02 | 1,515,151 | $0.66 | $1,000.00kBuy |
EYEN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when EYEN insiders and whales buy or sell their stock.
EYEN Shareholders
What type of owners hold Eyenovia Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Stuart M. Grant | 378.59% | 10,914,153 | $29.14M | Insider |
| Shuhei Yoshida | 60.77% | 1,751,900 | $4.68M | Insider |
| Senju Pharmaceutical Co Ltd | 59.61% | 1,718,566 | $4.59M | Insider |
| Fredric N. Eshelman | 56.15% | 1,618,835 | $4.32M | Insider |
| Curt H. Labelle | 22.51% | 648,903 | $1.73M | Insider |
| Ernest Mario | 13.28% | 382,706 | $1.02M | Insider |
| Ubs Group Ag | 6.91% | 199,320 | $532.18k | Institution |
| Michael M. Rowe | 3.82% | 109,998 | $293.69k | Insider |
| Jennifer G. Clasby | 2.31% | 66,537 | $177.65k | Insider |
| Kenneth B. Lee Jr. | 2.24% | 64,544 | $172.33k | Insider |
EYEN vs Biotech Stocks
Eyenovia Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.